(1S,5S)-3-(5,6-dichloro-3-pyridinyl)-3,6diazabicyclo[3.2.0]heptane is an effective analgesic agent

Details for Australian Patent Application No. 2004243270 (hide)

Owner Abbott Laboratories

Inventors Buckley, Michael J.; Ji, Jianguo

Agent Spruson & Ferguson

Pub. Number AU-B-2004243270

PCT Pub. Number WO2004/106342

Priority 10/445,555 27.05.03 US

Filing date 20 May 2004

Wipo publication date 9 December 2004

Acceptance publication date 17 December 2009

International Classifications

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2004/106342 Priority application(s): WO2004/106342

17 December 2009 Application Accepted

  Published as AU-B-2004243270

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004243271-Nozzle for generating high-energy cavitation

2004243267-Porous films